138 related articles for article (PubMed ID: 33235470)
1. Forkhead Box S1 Inhibits the Progression of Hepatocellular Carcinoma.
Lei D; Hu G; Chen Y; Hao T; Gao Y; Luo F
Onco Targets Ther; 2020; 13():11839-11848. PubMed ID: 33235470
[TBL] [Abstract][Full Text] [Related]
2. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
[TBL] [Abstract][Full Text] [Related]
3. FOXS1 is regulated by GLI1 and miR-125a-5p and promotes cell proliferation and EMT in gastric cancer.
Wang S; Ran L; Zhang W; Leng X; Wang K; Liu G; Song J; Wang Y; Zhang X; Wang Y; Zhang L; Ma Y; Liu K; Li H; Zhang W; Qin G; Song F
Sci Rep; 2019 Mar; 9(1):5281. PubMed ID: 30918291
[TBL] [Abstract][Full Text] [Related]
4. Forkhead Box S1 inhibits the progression of lung squamous cell carcinoma cells by mediating Wnt/β-catenin pathway.
Wang F; Li S
Chin J Physiol; 2022; 65(5):266-275. PubMed ID: 36308082
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.
Lu Q; Ma X; Li Y; Song W; Zhang L; Shu Y; Wan B
J Cell Biochem; 2019 Mar; 120(3):2897-2907. PubMed ID: 30500980
[TBL] [Abstract][Full Text] [Related]
6. FOXS1 promotes prostate cancer progression through the Hedgehog/Gli1 pathway.
Wang M; Huang W
Biochem Pharmacol; 2023 Dec; 218():115893. PubMed ID: 37890593
[TBL] [Abstract][Full Text] [Related]
7. FOXS1 Promotes Tumor Progression by Upregulating CXCL8 in Colorectal Cancer.
Qiu J; Li M; Su C; Liang Y; Ou R; Chen X; Huang C; Zhang Y; Ye Y; Liao W; Zhang C
Front Oncol; 2022; 12():894043. PubMed ID: 35898871
[TBL] [Abstract][Full Text] [Related]
8. TGFβ-induced FOXS1 controls epithelial-mesenchymal transition and predicts a poor prognosis in liver cancer.
Bévant K; Desoteux M; Angenard G; Pineau R; Caruso S; Louis C; Papoutsoglou P; Sulpice L; Gilot D; Zucman-Rossi J; Coulouarn C
Hepatol Commun; 2022 May; 6(5):1157-1171. PubMed ID: 34825776
[TBL] [Abstract][Full Text] [Related]
9. CD90
Xue BZ; Xiang W; Zhang Q; Wang HF; Zhou YJ; Tian H; Abdelmaksou A; Xue J; Sun MX; Yi DY; Xiong NX; Jiang XB; Zhao HY; Fu P
Stem Cell Res Ther; 2021 Jul; 12(1):394. PubMed ID: 34256854
[TBL] [Abstract][Full Text] [Related]
10. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
11. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
13. RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway.
Shi R; Liu Z
Cancer Cell Int; 2022 Apr; 22(1):150. PubMed ID: 35410346
[TBL] [Abstract][Full Text] [Related]
14. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
15. PAK3 promotes the metastasis of hepatocellular carcinoma by regulating EMT process.
Gao Z; Zhong M; Ye Z; Wu Z; Xiong Y; Ma J; Chen H; Zhu Y; Yang Y; Zhao Y; Zhang Z
J Cancer; 2022; 13(1):153-161. PubMed ID: 34976179
[No Abstract] [Full Text] [Related]
16. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
18. GDF11 inhibits the malignant progression of hepatocellular carcinoma via regulation of the mTORC1‑autophagy axis.
Wu Q; Fan C; Liu K; Tang J
Exp Ther Med; 2024 Jun; 27(6):252. PubMed ID: 38682112
[TBL] [Abstract][Full Text] [Related]
19. MiR-16 inhibits hepatocellular carcinoma progression by targeting FEAT through NF-κB signaling pathway.
Su XF; Li N; Meng FL; Chu YL; Li T; Gao XZ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10274-10282. PubMed ID: 31841182
[TBL] [Abstract][Full Text] [Related]
20. Significance of the hedgehog pathway-associated proteins Gli-1 and Gli-2 and the epithelial-mesenchymal transition-associated proteins Twist and E-cadherin in hepatocellular carcinoma.
Chun HW; Hong R
Oncol Lett; 2016 Sep; 12(3):1753-1762. PubMed ID: 27602109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
